Products - Structural heart defects | Topic

Showing 5 products

Date | Title

Heart valve disease in adults
Status:
Awaiting development
Expected publication date:
TBC
Eplontersen for treating transthyretin-related amyloidosis cardiomyopathy [TSID12015]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Interventional Correction of Superior Sinus Venosus Defect and Partial Anomalous Pulmonary Venous Drainage
Status:
Awaiting development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Elamipretide for treating Barth syndrome in people of any age [ID6545]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID6575]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC